» Articles » PMID: 11530970

The Minnesota Regional Peripheral Arterial Disease Screening Program: Toward a Definition of Community Standards of Care

Overview
Journal Vasc Med
Publisher Sage Publications
Date 2001 Sep 4
PMID 11530970
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The Minnesota Regional Peripheral Arterial Disease Screening Program was designed to define the efficacy of community PAD detection efforts, to assess the disease-specific and health-related morbidity, to assess PAD awareness rates, and to determine the magnitude of atherosclerosis disease risk factors and the intensity of their management. The target population was recruited via mass media efforts directed at individuals over 50 years of age and those with leg pain with ambulation. Screening sessions included assessments of the ankle-brachial index, blood pressure, fasting lipid profile, and use of validated tools to detect symptomatic claudication (by the Modified WHO-Edinburgh Claudication Questionnaire), walking impairment (Walking Impairment Questionnaire - WIQ), quality of life (MOS SF-36), PAD awareness, and the intensity of PAD medical therapeutic interventions. PAD was defined as any ankle-brachial index < or =0.85 or a history of lower extremity revascularization. The program evaluated 347 individuals and identified 92 subjects with PAD and 255 subjects without PAD, yielding a detection rate of 26.5%. Individuals with PAD were older, tended to have higher blood pressures, and had a significant walking impairment and an impaired health-related quality of life compared with the non-PAD subjects. Current rates of tobacco use were low. Lipid-lowering, estrogen replacement, anti-platelet, and antihypertensive medications and exercise therapies were underutilized in the PAD cohort. Peripheral arterial disease awareness was low in these community-identified patients. This Program demonstrated that individuals with PAD can be efficiently identified within the community, but that current standards of medical care are low. These data can assist in the future development of PAD awareness, education, and treatment programs.

Citing Articles

The association between socioeconomic distress communities index and amputation among patients with peripheral artery disease.

Witrick B, Shi L, Mayo R, Hendricks B, Kalbaugh C Front Cardiovasc Med. 2022; 9:1021692.

PMID: 36407449 PMC: 9668855. DOI: 10.3389/fcvm.2022.1021692.


The Edinburgh Claudication Questionnaire has poor diagnostic accuracy in people with intermittent claudication.

Ibeggazene S, Stirrup A, Pymer S, Palmer J, Cai P, Smith G Vascular. 2022; 31(1):115-121.

PMID: 35143731 PMC: 9936437. DOI: 10.1177/17085381211059665.


The burden and characteristics of peripheral arterial disease in patients undergoing amputation in Korle Bu Teaching Hospital, Accra, Ghana.

Bediako-Bowan A, Adjei G, Clegg-Lamptey J, Naaeder S Ghana Med J. 2018; 51(3):108-114.

PMID: 29622821 PMC: 5870231. DOI: 10.4314/gmj.v51i3.3.


Building a Critical Limb Ischemia Program.

Galmer A, Selim S, Giri J, Lau J, Weinberg M Curr Treat Options Cardiovasc Med. 2016; 18(8):50.

PMID: 27289583 DOI: 10.1007/s11936-016-0476-4.


β-Blockers and Vascular Hemodynamics in Patients With Peripheral Arterial Disease.

Schlager O, Gajdosova Kovacicova L, Senn O, Amann-Vesti B, Wilkinson I, Jacomella V J Clin Hypertens (Greenwich). 2016; 18(12):1244-1249.

PMID: 27279251 PMC: 8031715. DOI: 10.1111/jch.12854.